Kallmann syndrome (KS) and its normosmic variant—collectively known as congenital hypogonadotropic hypogonadism (CHH)—are principally characterised by isolated deficiency in the secretion or action of gonadotropin-releasing hormone (GnRH). The gene discussed is GNRH1; the disease is Kallmann syndrome.